Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

Over the past year, Haemonetics has reshaped its product portfolio through restructuring and M&A, adding devices used in ...

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the initiation of the EMBO-02 clinical study of NeoCast™ to treat chronic subdural ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...